FIELD: medicine, in particular, agent for prophylaxis and correction of immunodeficiency conditions.
SUBSTANCE: claimed agent represents heptapeptide of general formula Thr-Lys-Pro-Arg-Pro-Gly-Pro.
EFFECT: enhanced assortment of immunomodulating drugs, increased effectiveness of prophylaxis and treatment of immunodeficiency conditions.
5 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
| USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| USE OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE FOR PROTECTION OF INSULAR PANCREAS AND EXOCRINE SECTION THEREOF FROM TOXIC DESTRUCTIVE EFFECTS | 2023 |
|
RU2833679C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA | 2019 |
|
RU2709503C1 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE | 2011 |
|
RU2450822C1 |
